In the heart, HDAC11 deletion improved several parameters of diabetes mellitus-associated cardiac injury, including oxidative stress, apoptosis, inflammation and cardiac function [94], pointing to HDAC11 suppression as a potential therapeutic target for treating such a cardiac condition. Here, HDAC11 is linked to diabetes mellitus.